>Only in the footnotes was it disclosed that 0.06 of the 0.48 EPS was a one-time gain from canceling the company’s healthcare plan for retirees.<
Goddard is all class. Let's f up the company by buying a drug that everyone thought was a joke, and then to make up for the blunder, let's nickel and dime the retirees (who likely worked during the time that tarceva was in development).
Market Data 
Markets 
AI
